Download this slideset from a local live webinar to learn how to optimally manage your patients with hematologic malignancies using CAR T-cell therapy.
Two expert pharmacists answer audience questions from a live symposium on optimal current use of CAR T-cell therapies in patients with cancer.
Watch this on-demand webcast from a recent HOPA satellite symposium on CAR T-cells for hematologic malignancies, including new data, recent approvals, and treatment guidelines.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.